HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2011-07-25Clinical Trial Update: A Compassionate Access Protocol For Those Patients Who Have Completed A4001029
This clinical-trial update announces a compassionate-access protocol for patients who completed the A4001029 study in HIV, outlining continu…
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV [Phase 4]
A Phase 4 trial to identify the optimal antiviral dose for patients co-infected with tuberculosis and HIV has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users [Phase 4]
Phase 4 clinical trial comparing raltegravir to a protease inhibitor in treatment-naïve HIV/Hepatitis C drug users. The update provides no r…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia [Phase 3]
Phase 3 clinical trial evaluating substitution of atazanavir (with or without ritonavir boosting) for ritonavir-boosted protease inhibitors …
-
CLINICAL_TRIALS trial_result · 2011-07-20Clinical Trial Update: Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients [Phase 4]
A Phase 4 safety study evaluating the combination of lopinavir/ritonavir with raltegravir in HIV-infected patients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-07-20Clinical Trial Update: Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention [NA]
This trial compares web-based versus traditional adolescent HIV prevention approaches. The current status of the study is unknown.
-
CLINICAL_TRIALS trial_result · 2011-07-18Clinical Trial Update: Lopinavir Capsules to Kaletra or Invirase Tablets [Phase 4]
Phase 4 clinical trial update reporting completion of a study comparing Lopinavir capsules with Kaletra or Invirase tablets for HIV infectio…
-
CLINICAL_TRIALS research · 2011-07-18Clinical Trial Update: Effects of a Phone Call Intervention to Promote HAART Adherence [NA]
This entry reports an ongoing clinical trial evaluating whether a phone call intervention can improve adherence to HAART in people with HIV.…
-
CLINICAL_TRIALS trial_result · 2011-07-12Clinical Trial Update: TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors [Phase 3]
Phase 3 trial results comparing rilpivirine (TMC278) to efavirenz, both with two nucleoside reverse transcriptase inhibitors, in treatment-n…
-
CLINICAL_TRIALS trial_result · 2011-07-11Clinical Trial Update: TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine. [Phase 3]
Phase 3 trial in treatment-naive HIV-1 patients compares rilpivirine (TMC278) to efavirenz, both with tenofovir/emtricitabine; results were …
-
CLINICAL_TRIALS trial_result · 2011-07-11Clinical Trial Update: Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults [Phase 1]
Phase 1 study evaluating safety and pharmacokinetics of the UB-421 antibody in asymptomatic HIV-1 infected adults has completed.
-
FDA approval · 2011-07-08FDA Approved: TRUVADA — Supplemental Application (Gilead Sciences, Inc)
The FDA approved a supplemental application for TRUVADA (emtricitabine and tenofovir disoproxil fumarate) from Gilead Sciences, Inc., relate…
-
CLINICAL_TRIALS trial_result · 2011-07-07Clinical Trial Update: A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016) [Phase 1]
Phase 1 study evaluating the safety, tolerability, and immunogenicity of the MRKAd5 Gag/Pol/Nef HIV vaccine in healthy adults, with results …
-
CLINICAL_TRIALS trial_result · 2011-07-04Clinical Trial Update: Spatial Epidemiology of HIV Infection
This ClinicalTrials.gov entry reports a completed study on the spatial epidemiology of HIV infection, sponsored by National Taiwan Universit…
-
CLINICAL_TRIALS trial_result · 2011-07-01Clinical Trial Update: HIV Testing Strategies in the Perinatal Setting [NA]
Completed results for a trial evaluating HIV testing strategies in the perinatal setting have been posted.
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients [Phase 4]
This Phase 4 trial evaluated Fuzeon (enfuvirtide) in combination with an integrase inhibitor-based regimen and optimized background in treat…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: TMC278-TiDP6-C153 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC278 and Raltegravir [Phase 1]
Phase 1 study in healthy volunteers evaluating pharmacokinetic interaction between rilpivirine (TMC278) and raltegravir; the trial is comple…
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: A Long Term, Safety Study of Apricitabine in HIV-infected Subjects [Phase 2]
This clinical trial update reports the completion of a Phase 2 long-term safety study of apricitabine in HIV-infected subjects. It summarize…
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV [Phase 2]
Phase 2 trial update for AVX754, a new nucleoside reverse transcriptase inhibitor, in drug-resistant HIV; the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects [Phase 1]
Phase 1 study evaluating the cardiovascular safety of Apricitabine in healthy volunteers; the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together [Phase 1]
Phase 1 pharmacokinetic study evaluating apricitabine and tipranavir when dosed alone and in combination for HIV infection.
-
CLINICAL_TRIALS withdrawal · 2011-06-23Clinical Trial Update: A Long Term Safety Study of Apricitabine in HIV-infected Patients [Phase 3]
A Phase 3 long-term safety study of apricitabine in HIV-infected patients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Cognitive Behavioral Treatment to Reduce Alcohol Use Among HIV-Infected Kenyans [Phase 1]
Phase 1 clinical trial update evaluating cognitive behavioral therapy to reduce binge drinking and alcohol use among HIV-infected individual…
-
CLINICAL_TRIALS trial_result · 2011-06-20Clinical Trial Update: Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa [Phase 2]
A Phase 2 pharmacokinetics study evaluating rifabutin when combined with antiretroviral therapy in TB/HIV co-infected patients in South Afri…
-
CLINICAL_TRIALS research · 2011-06-20Clinical Trial Update: Trial of Safe Water Storage Among People Living With HIV [NA]
A clinical trial update about a study on safe water storage among people living with HIV, looking at diarrhea and waterborne disease outcome…